It has been previously shown in vitro that the human immunodeficiency virus type 1 long terminal repeat (LTR) is activated by ultraviolet irradiation. In order to analyze if a similar effect could occur in vivo, transgenic mice carrying the lacZ gene under the control of the viral LTR were irradiated at 280-300 and 254 nm. These mice spontaneously expressed the transgene in the epidermis and the lens of both adults and embryos.
Introduction
A variety of clinical syndromes, including AIDS, neurological disorders, and Kaposi's sarcoma may follow as a consequence of infection with the human immunodeficiency virus type 1 (HIV-1).' This etiological agent was shown to infect CD4' T lymphocytes, cells ofthe macrophage-monocyte lineage and of the central nervous system (1) . One of the characteristics of this prototype human lentivirus is the extended time frame, for months to years, from initial HIV infection to clinically detectable immunologic abnormalities and disease manifestations. Previous studies have shown that in addition to the HIV-1 regulatory proteins, physical, chemical, and other viral agents can act in vitro to activate the HIV-1 long terminal repeat (LTR) (2) (3) (4) . Since activation signals are required for the establishment ofthe productive HIV infection in vitro, it is likely that activators contribute to the conversion of a latent or chronic infection to a productive one in vivo. The identification of factors that induce in vivo viral expression could be of use in controlling the evolution of the disease. 1 . Abbreviations used in this paper: CAT, chloramphenicol acetyltransferase; HIV-1, human immunodeficiency virus type 1; LTR, long terminal repeat; UV, ultraviolet.
Transgenic mice carrying the viral LTR controlling the expression of a reporter gene can be used for studying the cellular and exogenous factors that may activate in vivo the HIV-l LTR. We have generated transgenic mice carrying an insert in which the U3R region of the HIV-I LTR is linked to the bacterial gene lacZ which encodes for the 8-galactosidase protein. This reporter gene allows a rapid and precise localization of expression.
We present in this report the spontaneous activity of the viral LTR in various tissues of transgenic mouse models and the evidence of its activation in the skin by ultraviolet (UV) B and C rays. Production oftransgenic mice. Before microinjection into fertilized eggs, the insert was purified from the vector sequences on a low melting point agarose gel and isolated by dissolution in 0.6 M sodium iodide on 325 mesh silica. The fragment was diluted for injection to 3.5 ng/Ol in 10 mM Tris-HCl pH 7.5, 0.1 mM EDTA. DNA (-300-500 copies per egg) was microinjected using established procedures into fertilized eggs resulting from mating between B6D2Fl hybrids (5) .
Methods
DNA analysis. 2-wk-old animals were screened for the insertions of the U3R-lacZ hybrid gene by Southern blot analysis of tail DNA preparations. Genomic DNA's (10 tg) were digested with Hind III and separated by electrophoresis through 1% agarose gels, then transferred to Zetabind filters (AMF-Cuno, Meriden, CT). Prehybridization and hybridization were carried out according to the supplier's recommendations. The probe was the microinjected fragment ( Fig. 1 B) labeled by the random priming method (6 Tail biopsies were performed before irradiation and 24, 48 h, and 6 d after.
Results
Generation of U3R-lacZ transgenic mice. Southern blot analysis of restriction enzyme-digested DNA from the tails of 18 live-born animals revealed that three contained integrated copies of the hybrid gene ( Fig. 1 A) . In transgenic lines 6, 10, and 17, the transgene was organized as a head to tail tandem array. Copy number ranged from -5 to 100 (data not shown). Analysis of the progeny of these founder animals showed that the transgene was transmitted at a frequency of -50%.
Expression ofthe transgene in the adult mice. Expression of the hybrid gene was assayed by a sensitive enzymic in situ detection procedure for E. coli f3-galactosidase, in which the chromogenic substrate, X-gal, is enzymically cleaved by f3-galactosidase to release an insoluble blue dye. Expression was first investigated in the adult mice by examination of cryostat sections for fl-galactosidase activity. Among all the organs tested (brain, thymus, heart, lung, liver, spleen, pancreas, kidney, muscles, skin, and eye), the skin and the eyes spontaneously expressed the transgene. The same pattern of expression was detected in two independent strains.
In the eye, the fl-galactosidase activity was restricted to some fiber lens cells ( Fig. 2 a and b ) located in the cortical region of the lens known to contain the most recently formed fiber cells during embryonic development. In the skin, expression was limited to the epidermis and was associated with both hair follicles and cells interspersed throughout the stratum corneum ( Fig. 2 c and d) . In both cases, the majority of the cells producing the protein were anucleated, suggesting that they were at the ultimate stage of differentiation. Expression in the skin was variable according to the sites of biopsies. The activity was reduced in fur-bearing skin (dorsal and ventral side of the mice) compared with the ears and the tail.
Expression ofthe transgene in the embryos. The same pattern ofexpression observed in adults was found in the embryos of the two strains expressing the transgene. Activity in the eyes was detectable from gestational age (G) 11 and persisted until birth. At G 15, the staining in the lens was clearly visible even without sectioning as it is shown in Fig. 3 a. Examination of cryostat sections showed that f3-galactosidase activity was located in a few lens fibers ( Fig. 3 b and b' ). Besides the lens staining, an intense external staining of the embryo was apparent. Examination of fetuses revealed that the lacz gene was strongly expressed over almost the entire skin surface. In addition to the keratinized peridermal cells, a few cells surrounding the hair follicle were also stained (Fig. 3 c) 1372 Cavard, Zider, Vernet, Bennoun, Saragosti, Grimber, and Briand activity in peridermal cells was constant all through the gestation and staining was markedly more elevated than that observed in epidermal keratinocytes after birth.
UV-induced gene expression. Previous in vitro experiments led to the hypothesis that UV irradiation could affect HIV-1 expression in vivo (4, 7, 8) . To test this hypothesis, irradiations at 280-320 (UV B rays) and 254 nm (UV C rays) were performed on 10-d-old mice. In both cases, a significant increase in 13-galactosidase activity compared with control animals was observed on skin biopsy sections (Fig. 2 g and h) . This effect was detected within 24 h after irradiation and persisted for 24 h at the same level. The activating effect was obtained in a dose-dependent manner with a peak at 60 J after 10 min or 30 s of exposure under UV B and UV C irradiation, respectively. Expression was shown to decrease at increasing doses up to 180 (i.e., 30 min) and 90 J (i.e., 45 s) for UV B and UV C, respectively. 6 d later, the activating effect had completely disappeared even though an epidermic hyperplasia associated with a marked hyperkeratosis was still detectable. No effect had been detected with UV A irradiation.
Discussion
We generated three transgenic lines carrying the HIV-1 LTRlacZ transgene. In one strain (n = 6), the absence ofany detectable activity suggested that the injected sequence had incorporated into a region of inactive chromatin or sustained an undetectable sequence alteration. The pattern of expression was characterized in the two other independent strains by a marked fB-galactosidase activity in the lens and in the skin and thus appeared to be conferred by the HIV-1 LTR. The pattern of expression in these transgenic mice carrying a U3R-lacZ transgene is similar to the one described in another transgenic model in which the HIV LTR is linked to the chloramphenicol acetyltransferase (CAT) gene. In that model, expression was also observed in the thymus (9) . We cannot exclude the possibilities that a low level of /-galactosidase production in this organ would not be detected by the staining method used or that this enzyme would be less stable in this tissue than the CAT protein. The level of mRNA encoded by the transgene in the thymus is now under investigation by in situ hybridization. The transgene expression found in the skin and the eyes clearly confirmed that an expression driven by the HIV-1 LTR could be possible in vivo even in the absense of the viral transactivator TAT protein. This suggests that in vivo specific cellular factors could supply the action of TAT protein.
The direct in situ detection of the enzymatic activity in our model has allowed us to locate precisely in which cells of the epidermis the HIV-1 LTR directed expression could occur. The expressing cells were predominantly keratinocytes by nature of their terminal differentiation. A high activity was also observed around the hair follicles. Altogether, these localizations might explain some of the pathological modifications (epidermal hyperplasia and particularly nodular proliferation of mature keratinocytes in submandibular masses) observed in transgenic mice carrying the entire HIV-1 genome (10). Furthermore, transgenic mice carrying the LTR-TAT transgene exhibit, as the earliest lesion in the skin, an epidermal hyperplasia before the development of a Kaposi's like syndrome (I 1).
In the previously reported LTR-CAT model (9), the CAT activity was detected predominantly in the Langerhans cells but also in keratinocytes. If we assumed that the reporter genes, CAT and lacZ, were neutral and the pattern of expression was specific of the HIV-1 LTR, an explanation for this difference could be that the in vitro culture step used by Leonard et al. (9) Under UV induction, the cell types in which the staining was detected were in the same location as those in which the HIV-LTR was spontaneously active, that is, in the external cornified layer of the epidermis. UV irradiation might act directly on keratinocytes or indirectly by promoting the secretion of an extracellular factor by irradiatud cells, which in turn may activate the HIV-1 transcription in other cell types, as suggested by in vitro experiments (7) (8) . Like a number of eucaryotic promoters such as c-fos, metallothionein, and collagenase, known to be susceptible to DNA damaging agents and phorbol esters (7) , retroviral promoters might be activated during the cascade of events triggered by the stress response. It has been recently reported that such activations by UV, x ray, and phorbol myristate acetate could occur in vitro for the Moloney murine sarcoma virus LTR (12) . This effect is mediated by activation of the protein kinase C and would be independent of newly synthesized proteins. In vivo activation reported in this work appeared to follow the same kinetics of response to UV stimulation as has been described in vitro for both viruses, although their final mechanisms of activation could be different.
Pathological phenomena induced by UV rays in HIV-infected cells could be enhanced by a cumulative effect linked to the DNA damages produced, and to the downregulation of DNA reparation processes presumably induced by some lentivirus. Host Our results demonstrate that UV B (and UV C) rays can activate HIV-1 expression in vivo. The doses described in our model are severalfold higher than those previously described for cultured cells, but may be a better representation of the natural phenomenon which occurs during a prolonged exposure to sunlight. These results also suggest that UV B irradiation might be involved in viral activation, triggering an expression of HIV-1 sequences in cell types different from those previously shown to be the major source of the virus in the skin, and explaining some of the skin pathology observed during HIV-1 infection.
